1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Endocrine Testing Market
2.2. Global Endocrine Testing Market, By Test, 2023 (US$ Million)
2.3. Global Endocrine Testing Market, By Disorder, 2023 (US$ Million)
2.4. Global Endocrine Testing Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Endocrine Testing Market: Competitive Analysis
3.1. Market Positioning of Key Endocrine Testing Market Vendors
3.2. Strategies Adopted by Endocrine Testing Market Vendors
3.3. Key Industry Strategies
4. Endocrine Testing Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Endocrine Testing Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Estradiol (E2) Testing
5.3.2. Follicle Stimulating Hormone (FSH) Testing
5.3.3. Human Chorionic Gonadotropin (hCG) Hormone Testing
5.3.4. Luteinizing Hormone (LH) Testing
5.3.5. Dehydroepiandrosterone Sulfate (DHEAS) Testing
5.3.6. Progesterone Testing
5.3.7. Testosterone Testing
5.3.8. Thyroid Stimulating Hormone (TSH) Testing
5.3.9. Prolactin Testing
5.3.10. Cortisol Testing
5.3.11. Insulin Testing
5.3.12. Others

6. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Adrenal Disorders
6.3.2. Calcium-Related Disorders
6.3.3. Glucose (Islet Cells) Disorders
6.3.4. Male and Female Gonadal Problems
6.3.5. Hypertensive & Heart Disorders
6.3.6. Thyroid Disorders
6.3.7. Pituitary Disorders


7. North America Endocrine Testing Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
7.3. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
7.4.Endocrine Testing Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
7.4.1.1.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
7.4.1.2.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
7.4.1.3.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)

8. UK and European Union Endocrine Testing Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
8.3. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
8.4.Endocrine Testing Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
8.4.1.1.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
8.4.1.2.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
8.4.1.3.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
8.4.1.4.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
8.4.1.5.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
8.4.1.6.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)

9. Asia Pacific Endocrine Testing Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
9.3. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
9.4.Endocrine Testing Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
9.4.1.1.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
9.4.1.2.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
9.4.1.3.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
9.4.1.4.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
9.4.1.5.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
9.4.1.6.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)

10. Latin America Endocrine Testing Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
10.3. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
10.4.Endocrine Testing Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
10.4.1.1.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
10.4.1.2.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
10.4.1.3.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)

11. Middle East and Africa Endocrine Testing Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
11.3. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
11.4.Endocrine Testing Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
11.4.1.1.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
11.4.1.2.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Endocrine Testing Market: By Test, 2022-2032, USD (Million)
11.4.1.3.2. Endocrine Testing Market: By Disorder, 2022-2032, USD (Million)

12. Company Profile
12.1. Abbott Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Agilent Technologies
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. bioMerieux S.A.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Bio-Rad Laboratories, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. DiaSorin S.p.A.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. F. Hoffmann-La Roche AG
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Ortho Clinical Diagnostics
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. SCIEX (Danaher Corporation)
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Siemens AG
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Thermo Fisher Scientific, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives